Dylan Rock
Story Poster
17:57
Jim Schlossnagle discusses Texas A&M's weekend in Baton Rouge
4 days ago by Ryan Brauninger
No. 3 Texas A&M baseball dropped its second series of the year on the road at LSU. Head skipper Jim Schlossnagle joined Monday's edition of TexAgs Radio to offer his thoughts on the three-game set and A&M's final midweek game, hosting Rice on Tuesday evening.
Story Poster
42:06
Ask Liucci: Elko's offseason returns, A&M's hardwood slide & more
2 mo ago by Billy Liucci
A&M football is preparing to open its first spring camp under Mike Elko, while Aggie basketball is on the verge of missing the 2024 NCAA Tournament. TexAgs' co-owner and executive editor Billy Liucci tackled topics surrounding both programs and more in this edition of Ask Liucci.
Story Poster
71:06
Lunch with Liucci: Billy Liucci joins TexAgs Radio (Friday, February 23)
2 mo ago by Billy Liucci
TexAgs co-owner and executive editor Billy Liucci joined TexAgs Radio on Friday morning to discuss all things Texas A&M. "The Source" also talked about Aggie baseball's potential this season, Johnny Manziel's recent appearance on Club Shay Shay and much more.
Story Poster
Baseball Thoughts: SEC grind rolls along as A&M keeps finding success
1 yr ago by Ryan Brauninger
Texas A&M baseball has won four straight SEC series, but as Jim Schlossnagle and the Aggies know all too well, the past never equals the future. After showing plenty of toughness in Lexington, the Maroon & White face another challenge this weekend in Fayetteville.
Story Poster
12:24
D1Baseball's Kendall Rogers breaks down stacked SEC ahead of Opening Day
1 yr ago by David Nuño
Baseball season is upon us, and D1Baseball's Kendall Rogers joins Wednesday's edition of TexAgs Radio to give us all the top storylines before Friday's Opening Day. Rogers details A&M's key returners, SEC frontrunners and what teams to keep an eye out for.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.